February 13, 2021  NovaSterilis working  with medical device manufacturers and regulators to reduce EO emissions.  https://www.packagingdigest.com/medical-packaging/medical-device-makers-see-progress-eo-sterilization 

February 9, 2021  NovaSterilis will present at the Advanced Regenerative Manufacturing Institute’s workshop on March 11, 2021.  The workshop topic is Scaffold Fabrication Tools and Equipment.  Tony Eisenhut, CEO of NovaSterilis, will present Supercritical Carbon Dioxide: A Terminal Sterilization Solution for Bio-based
Materials.  Register for the event at https://www.armiusa.org/events/2021/2/11/a-template-for-the-future-of-biomanufacturing-virtual-workshop-series-zh2np


August 21, 2020  The FDA issued an emergency use authorization (EUA) to NovaSterilis, Inc. for its Nova2200, which uses the NovaClean decontamination process. Nova2200 can be used to decontaminate compatible N95 respirators for single-user reuse by healthcare personnel (HCP) to prevent exposure to pathogenic biological airborne particulates when there are insufficient supplies of face-filtering respirators (FFRs) during the COVID-19 pandemic.  https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-august-21-2020

August 1, 2020 Surfaces in Biomaterials Foundation Summer 2020 newsletter chronicles NovaSterilis’ and iFyber’s rapid mobilization of resources to address demands for reprocessing of PPE in support healthcare providers through COVID-19 pandemic. https://www.surfaces.org/resources/Documents/SurFACTS/2020/SurFACTS%20Summer%202020.pdf

February 18, 2020 NovaSterilis places NovaGenesis benchtop supercritical CO2 system at Universidade de Santiago de Compostela prior to the university hosting “EIFS 2020, the First Iberian Meeting on Supercritical Fluids”  https://flucomp.es/eventos/eifs2020

February 2, 2020  NovaSterilis technical team co-authors paper published in Biochimica et Biophysica Acta (BBA) – Proteins and Proteomics titled “Sterilization of epidermal growth factor with supercritical carbon dioxide and peracetic acid; analysis of changes at the amino acid and protein level” https://www.sciencedirect.com/science/article/abs/pii/S1570963919302195


November 25, 2019 The FDA choses NovaSterilis to work directly with the FDA on new approaches to medical device sterilization focused on identifying alternatives to ethylene oxide (EtO) sterilization methods. https://www.fda.gov/medical-devices/general-hospital-devices-and-supplies/fda-innovation-challenge-1-identify-new-sterilization-methods-and-technologies

October 1, 2019 Advanced Regenerative Medicine Institute (ARMI) features NovaSterilis in its new member spotlight. https://www.armiusa.org/news/2019/10/1/new-member-spotlight-novasterilis